, July 21
/PRNewswire/ -- EndoChoice, Inc. today announced that it has moved its corporate headquarters to a new location in Alpharetta, Georgia
. The new 30,000 square foot corporate headquarters is three times larger than its previous facility, and features a state-of-the-art GI anatomic pathology laboratory.
"We are very pleased with a seamless move into our new corporate headquarters," stated EndoChoice CEO and Founder Mark Gilreath. "With space for the R&D of GI devices and supplies, and a GI specialty diagnostic laboratory, our new facility highlights the complete focus on endoscopy that makes EndoChoice truly unique to the medical technology industry."
EndoChoice Pathology is a national reference laboratory accredited by the College of American Pathologists (CAP). The GI specialty laboratory is led by Medical Director, Dr. Robert Smith. "Our recent lab expansion and investments in technology enable EndoChoice to provide unmatched service to the GI physician. It's a very exciting time for our company," said Smith.
About EndoChoice, Inc.
EndoChoice designs, manufactures and markets innovative solutions for professionals in gastrointestinal endoscopy worldwide. Its diverse portfolio of high-quality devices, supplies, equipment, and pathology services uniquely positions EndoChoice as a leading resource for GI professionals. The company strives to exceed its customers' expectations through its superior products, exemplary customer care, knowledgeable sales force, and easy online ordering. For more information, visit www.EndoChoice.com.
SOURCE EndoChoice, Inc.